Google
×

Darusentan

Compounds
Darusentan is an endothelin receptor antagonist. Gilead Colorado, a subsidiary of Gilead Sciences, under license from Abbott Laboratories, is developing darusentan for the potential treatment of uncontrolled hypertension. In June 2003, Myogen... Wikipedia
ChEMBL Id: 23261
ChemSpider ID: 154336
IUPHAR ID: 3508